ReviewAntibody therapeutics2022

Role of antibody engineering in generation of derivatives starting from MOv19 MAb: 40 years of biological/therapeutic tools against folate receptor alfa.

Barbara Frigerio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.